【レポートの概要（一部）】
1. Executive Summary
1.1 Market Highlights
1.2 Overview of the Report Content
1.3 Research and Analysis Methods
1.4 Glossary of Terms Related to Telemedicine
2. An Introduction to Telemedicine and Telehealth
2.1 Telemedicine, Telehealth, and Telecare: A Concise Definition
2.1.1 Telecare: An All-Encompassing Field
2.1.2 Telehealth: For Monitoring and Health Maintenance
2.1.3 Telemedicine: Consultation, Diagnosis, Treatment
2.2 Rising Disease Prevalence: A Global Picture
2.3 Telemedicine: A Journey through History
2.4 mHealth: Mobile Communications to Transform Healthcare
2.5 Commonly Used Measuring Devices in Telemedicine
2.5.1 Blood Glucose Monitors
2.5.2 Blood-Pressure Monitors
2.5.3 Weight Scales
2.5.4 Pulse Oximeters
2.5.5 Peak Flow Meters
2.6 Medical Devices Classification Systems
2.6.1 The US Medical Devices Classification System
2.6.2 The EU Medical Devices Classification System
2.7 Regulation of Medical Devices
2.7.1 The US Approval and Regulation System
2.7.2 The EU Approval and Regulation System
2.7.2.1 Post-marketing Surveillance in the EU
3. The Global Telemedicine Market: by Therapeutic Indication 2014-2024
3.1 The Global Medical Device Market in 2013
3.2 Telemedicine: Global Market Overview
3.2.1 The Global Telemedicine Devices Market in 2013
3.2.2 Global Telemedicine Devices: Market Forecast 2014-2024
3.2.3 Changing Market Shares by Sector 2014-2024
3.3 Telemedicine Devices for Cardiac Diseases Market 2014-2024
3.3.1 Cardiac Diseases: A Major Cause of Death in Developed Economies
3.3.2 Telemedicine Devices for Cardiac Diseases: Market Forecast 2014-2024
3.4 Telemedicine Devices for COPD and Asthma Market 2014-2024
3.4.1 COPD and Asthma: Rising Prevalence
3.4.2 Telemedicine Devices for COPD and Asthma: Market Forecast 2014-2024
3.5 Telemedicine Devices for Diabetes Market 2014-2024
3.5.1 Diabetes: Rapid Technological Advances in Monitoring and Treatment
3.5.2 Telemedicine Devices for Diabetes: Market Forecast 2014-2024
3.6 Telemedicine Devices for Mental-health Related Illnesses Market 2014-2024
3.6.1 Telemedicine Devices for Use in Mental-health Related Illnesses
3.6.2 The Issue of Capacity, Consent, and Privacy in the Treatment of Mental Disorders
3.6.3 Cognitive Behaviour Therapy and the Use of Apps in the Management of Mental Disorders
3.6.4 The Phyode W/ME and the Life Spectrum Analyzer
3.6.5 Telemedicine Devices for Mental-health Related Illnesses: Market Forecast 2014-2024
3.7 Telemedicine Devices Used in the Treatment of Other Illnesses
3.7.1 Obstructive Sleep Apnea and Post Traumatic Stress Disorder
3.7.2 Telemedicine Devices Used in the Treatment of Other Illnesses: Market Forecast 2014-2024
4. Leading National Markets 2014-2024
4.1 The Telemedicine Devices Market by Regional Revenue
4.1.1 The Global Distribution of Telemedicine in 2013
4.2 Leading National Markets: Forecast, 2014-2024
4.2.1 Changing Market Shares by Region, 2014-2024
4.3 Regional Telemedicine Devices Markets: Analysis and Forecasts, 2014-2024
4.3.1 United States: The Largest Telemedicine Market
4.3.2 The EU5 Markets: Increasing Focus on Access to Quality Healthcare
4.3.2.1 EU5: Changing Market Shares by Country, 2014-2024
4.3.2.2 Germany: Biggest European Telemedicine Market
4.3.2.3 The UK: Government Initiatives Driving Telemedicine Uptake
4.3.2.4 France: A Tale of Reimbursement Struggles and Cost Cutting
4.3.2.5 Spain: Austerity Drive Weighing On Medical Technology
4.3.2.6 Italy: Ageing Population and Reforms in Healthcare Financing
4.3.3 Japan: Language Barrier and Complex Regulatory Guidelines Hindering Growth
4.3.4 China: A Great Leap Forward in Teleconferencing
4.3.5 South Korea: Rebranding Efforts Will Contribute to Market Growth
4.3.6 Russia: Pressing Need for Healthcare Extension to Remote Territories
4.3.7 India: A Rapidly Growing Medical Technology Market
4.3.8 Brazil: Social Inequalities and Uneven Healthcare Distribution
5. Telemedicine, Telehealth, and mHealth: Analysis and Trends
5.1 Telemedicine as a Package of Connected Devices
5.1.1 Telemedicine: Applications and Uses
5.1.2 Telemedicine: Issues Surrounding its Implementation
5.2 Factors Which Could Facilitate Telemedicine Development
5.2.1 The Establishment of National Agencies
5.2.2 Collaboration between Scientific Bodies
5.2.3 Legislative Interventions: The Affordable Care Act
5.3 mHealth
5.3.1 Mobile Devices Have the Potential to Become Powerful Medical Tools
5.3.2 The Rise of Mobile Medical Applications
5.3.3 Functions of mHealth
5.3.4 mHealth and GPS Tracking: A Possible Marriage with Benefits
5.3.5 The mHealth Initiative: An ITU and WHO Partnership
5.3.6 Overcoming the Obstacles to mHealth Uptake
5.3.7 Recommended Actions for Increasing mHealth Uptake
5.3.7.1 Maintain Low Costs
5.3.7.2 Gain the Approval of the Healthcare Practitioners
5.3.7.3 Solutions Should Offer Ease of Use and Increased Efficiency
5.3.8 V-Patch and Zensor: Remote monitoring From Intelesens
5.4 Pipeline Projects
5.4.1 CareLink System – Medtronic
5.4.2 CX65 mobile phone – Siemens
5.4.3 Telemonitoring System for Dementia Patients – Intel
5.4.4 MDKeeper Wearable eHealth System – Aerotel Medical Systems
6. Leading Companies in the Telemedicine Market 2014
6.1 3M: A Global Health Information Systems Provider
6.1.1 3M Healthcare Revenue Analysis, 2013
6.1.2 3M’s Telemedicine Products and Services
6.2 Aerotel Medical Systems
6.2.1 Aerotel’s Products and Services
6.3 AGFA Healthcare
6.3.1 AGFA: Radiology and Imaging Solutions
6.4 AMD Global Telemedicine Inc
6.4.1 AMD Global Telemedicine’s Products and Services
6.5 CardioComm
6.5.1 CardioComm Pipeline Products
6.6 Honeywell HomMed
6.6.1 Honeywell HomMed Telemedicine Products and Services
6.7 Medtronic
6.7.1 Medtronic: Revenue Analysis
6.7.2 Medtronic’s Telemedicine System
6.8 Philips Healthcare
6.8.1 Philips Healthcare: Revenue Analysis
6.9 Siemens Healthcare
6.9.1 Siemens Healthcare: Revenue Analysis
6.10 Telcare
6.10.1 Telcare’s Market and Business Model
6.10.2 Telcare’s Products and Services
7. Qualitative Analysis
7.1 SWOT Analysis of the Telemedicine Devices Market, 2014-2024
7.2 Strengths
7.2.1 The Increasing Prevalence of Diseases
7.2.2 The Rising Popularity of Home Monitoring
7.2.3 The Willingness of Telecommunication Companies to Invest
7.3 Weaknesses
7.3.1 The Threat of Replacement Perceived by Healthcare Professionals
7.3.2 The Inter-dependence of Telemedicine and Other Infrastructure
7.4 Opportunities
7.4.1 Potential for Use in Clinical Trials
7.4.2 Possibility of Integrating with Assisted Living
7.4.3 Benefits to Society beyond Healthcare
7.5 Threats
7.5.1 The High Cost of Implementing Telemedicine
7.5.2 High Barrier to Entry: A Strong Deterrent
7.5.3 Reluctance of Organisations to Share and Exchange Knowledge
8. Expert Opinion
8.1 Interview with Ms Stacey Force, Vice President of Marketing, Honeywell HomMed
8.1.1 The Scope of Telemedicine, Telehealth and Telemonitoring
8.1.2 On the Current State of the Telemedicine and Telehealth Market
8.1.3 On the Size of the Telemonitoring Market
8.1.4 Honeywell’s Products and Service Offerings
8.1.5 Honeywell’s Plans for Expansion and Growth
8.1.6 The Challenges Facing Telemedicine
8.1.7 Technological Developments and their Potential Impact on the Market
8.1.8 The Changing Reimbursement Model and Cost-Effectiveness
8.2 Interview with Mr. Jason Gorevic, Chief Executive Officer, Teladoc
8.2.1 Trends in the Development and Adoption of Telemedicine
8.2.2 Teleadoc’s Services and Healthcare Partnerships
8.2.3 Plans for Future Expansion of Telemedicine Services and Mobile Engagement
8.2.4 On the Challenges and Unmet Needs in the Market
8.2.5 Technological Developments in Remote Healthcare Provision
8.2.6 On the Future Prospects of Telemedicine
8.3 Interview with Mr David Rubin, Chief Executive Officer, Aerotel Medical Systems
8.3.1 Current State of Telemedicine
8.3.2 Aerotel’s Products and Service Offerings
8.3.3 Challenges Facing Telemedicine and Telehealth
8.3.4 Opportunities for Market Growth
8.4 Interview with Mr Amnon Gavish, Senior Vice President of Vertical Solutions, Vidyo; and Mr Marty Hollander, Vidyo Evangelist, Vidyo
8.4.1 Telepresence as a Means of Improving Healthcare Efficiency
8.4.2 Vidyo’s Teleconferencing Solutions
8.4.3 Technological Advances in Telemedicine and its Effects on Market Dynamics
8.4.4 Vidyo’s Expansion and Growth Plans
8.4.5 The Geographical Areas That Will Drive Telehealth Growth
8.4.6 On the Future Potentials of Telemedicine and Teleconferencing
8.4.7 On the Challenges and Opportunities in the Telemedicine Market
9. Conclusion
9.1 Market Overview
9.2 Telemedicine Devices for Diabetes Care Set for Rapid Growth
9.3 Technologically Developed Economies will Drive Market Growth
【レポート販売概要】
■ タイトル：テレメディスン（遠隔医療）機器市場（2014-2024）■ 英文：Telemedicine Devices Market Forecast 2014-2024
Telehealth, mHealth & Future Prospects for Leading Companies
■ 発行日：2014年3月
■ 調査会社：visiongain
■ 商品コード：Visiongain-4052641
■ 調査対象地域：グローバル
- 血液癌治療の世界市場2019-2023About this market Leukemia is the most common type of cancer in children and also accounts for the highest mortality rate among cancers in pediatric patients. The prevalence of leukemia has been increasing at a significantly high rate. The incidence of other types of blood cancer such as lymphomas is also another factor driving the growth of the market, as it is leading to vendors conducting resea …
- MVNO Business Plan with Financial Modeling Spreadsheet 2011This is a full business plan based on the launch of an illustrative Mobile Virtual Network Operator (MVNO) known as Contendus. The plan covers all aspects of the company launch plan including market assessment, funding requirements, financial analysis, market segmentation and product differentiation. Also included is go-to-market plan, distribution and replenishment plans, comparison of MVNO's and …
- Diabetic Gastroparesis：グローバル臨床試験レビューH2, 2013Diabetic Gastroparesis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Diabetic Gastroparesis Global Clinical Trials Review, H2, 2013" provides data on the Diabetic Gastroparesis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Gastroparesis. It includes an overview of the trial numbers and …
- Petroleos de Venezuela S.A.：石油・ガスの開発・生産動向及びコスト分析- 2012Petroleos de Venezuela S.A. Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Petroleos de Venezuela S.A. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essentia …
- 麻酔気化器の世界市場2016-2020About Anesthesia Delivery System An anesthesia delivery system, which includes anesthesia machine and a breathing circuit, supports in pain management just before the surgical (pre-surgical) procedure. The anesthesia machine includes an anesthesia vaporizer, where the vaporizer mixes both anesthetic agent and oxygen together and delivers to the individual during the pre-surgical procedure through …
- モノクローナル抗体の世界市場：パイプラインインサイトEver since the Nobel Prize was bestowed on the person who invented the technology which enabled the preparation of monoclonal antibodies in 1984, their use has considerably expanded far beyond the scientific realm. Paul Ehrlich framed a hypothesis that a “magic bullet” could be developed with an objective of targeting selective diseases. With the introduction and development of hybridoma technolog …
- 世界のカーボンナノチューブ市場動向（2014-2018）TechNavio's analysts forecast the Global Carbon Nanotubes market to grow at a CAGR of 11.53 percent over the period 2014-2018. One of the key factors contributing to this market growth is the potential of carbon nanotubes to replace other materials. The Global Carbon Nanotubes market has also been witnessing the increase in production capacities by various vendors. However, the high cost of produc …
- Service Delivery Platforms The SOA-enabled Path to Integrate Legacy and IMS Networks (with Revenue Forecast 2010-2016)Service Delivery Platform (SDP) can be loosely defined as a standards based framework that facilitates the design, development, implementation and management of services required to run the operations of network services providers. The services could range from the basic voice connectivity to the state-of-the-art rich multimedia services. The most critical value-addition offered by the SDP methodo …
- 心筋虚血症(Myocardial Ischemia）：治療薬のグローバル治験動向（2014年下半期）Myocardial Ischemia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Myocardial Ischemia Global Clinical Trials Review, H2, 2014" provides data on the Myocardial Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myocardial Ischemia. It includes an overview of the trial numbers and their recru …
- 神経血管装置の世界市場：治療用途別（脳卒中、脳動脈狭窄、脳動脈瘤）装置種類別、地域別、セグメント予測The global neurovascular devices market size is estimated to reach USD 3.1 billion by 2026, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 5.3% over the forecast years. Preference for minimally invasive surgeries in the treatments of brain aneurysm and stroke is expected to be the key factor augmenting the market growth. Technological advancem …
- 2014年戦略提言：Mononucleosis診断検査市場The report presents a detailed analysis of the Mononucleosis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Mononucleosis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals &nbs …
- アルミニウム線材の世界市場2015-2019Technavios market research analyst predicts the global aluminum wire rods market to grow at a CAGR of around 2% during the forecast period. The increased investments in infrastructure are driving the growth of this market. Developing economies such as India are heavily investing in infrastructure activities to improve industrialization. Initiatives like "Make in India" are anticipated to increase …
- 医薬品有効成分/APIの世界市場予測（～2021）：種類別（新薬、ジェネリック）、メーカー別、合成別、製品別、薬品別、治療別The global active pharmaceutical ingredients market is expected to reach USD 213.97 Billion by 2021 from USD 157.95 Billion in 2016, growing at a CAGR of 6.3% from 2016 to 2021. The market is segmented on the basis type, type of manufacturer, type of synthesis, type of drug, therapeutic application, and region. Market growth is driven by the increasing incidence of chronic diseases, rising prevale …
- 世界のレンサ球菌検査市場The report presents a detailed analysis of the Streptococci diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Streptococci definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/P …
- エンタープライズラベリングソフトウェアの世界市場2019-2023About this market Integration of enterprise labeling with supply chain to drive growth in the market. An efficient supply chain of a product based company helps drive top line revenues. Each product manufactured in a company is attached to a label consisting of product data, transport description, and regulatory data information. Enterprise labeling software helps businesses in logistics, and reso …
